Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,785 | -36,699 | -38,980 | -23,234 | -7,658 |
| Depreciation Amortization | 1,141 | 738 | 760 | 420 | 202 |
| Accounts receivable | -663 | -755 | N/A | N/A | N/A |
| Other Working Capital | 5,435 | -5,766 | 4,211 | 2,959 | 532 |
| Other Operating Activity | 6,378 | 11,685 | 7,599 | 7,714 | 956 |
| Operating Cash Flow | $-32,494 | $-30,797 | $-26,411 | $-12,142 | $-5,968 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,000 | 18,500 | -18,500 | 0 | 0 |
| PPE Investments | -595 | 81 | -1,854 | -1,030 | -516 |
| Purchase Of Investment | -9,949 | -15,134 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -175 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -175 | 0 |
| Investing Cash Flow | $4,456 | $3,447 | $-20,354 | $-1,205 | $-516 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 58,885 | 50,881 | 4,182 | 66,163 | 16,415 |
| Other Financing Activity | -271 | -91 | 0 | -4,159 | -1,410 |
| Financing Cash Flow | $58,614 | $50,790 | $4,182 | $62,004 | $15,005 |
| Beginning Cash Position | 44,440 | 21,000 | 63,584 | 14,926 | 6,405 |
| End Cash Position | 75,016 | 44,440 | 21,000 | 63,584 | 14,926 |
| Net Cash Flow | $30,576 | $23,440 | $-42,583 | $48,658 | $8,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,494 | -30,797 | -26,411 | -12,142 | -5,968 |
| Capital Expenditure | -595 | -46 | -1,854 | -1,030 | -516 |
| Free Cash Flow | -33,089 | -30,843 | -28,265 | -13,171 | -6,484 |